Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders
- PMID: 15965996
- DOI: 10.1002/da.20067
Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders
Abstract
Primary health care clinics are increasingly providing psychiatric/psychological treatment of anxiety disorders, particularly for patients who do not have adequate access to specialty mental health services. Adequate treatment requires knowledge of and attention to patients' beliefs about available treatment options. The current investigation examined beliefs about psychotropic medications and psychotherapy among a sample of primary care patients with anxiety disorders. The influence of key demographic variables on strength of these beliefs was also explored. The presence of specific anxiety disorders was not found to impact strength of beliefs about either type of treatment. In contrast, there was a trend for the presence of depression to relate to more favorable attitudes toward psychotropic medication. Consistent with previous studies, ethnic minority patients reported less favorable attitudes toward both psychotropic medications and psychotherapy. These findings underscore the importance of assessing patient beliefs prior to the initiation of either psychotropic medications or psychotherapy across diagnostic and demographic groups. Practitioners should be particularly alert to the possibility that patients with anxiety disorders and members of ethnic minority groups may have less favorable attitudes toward treatment options. Treatment adherence may therefore be increased by addressing these beliefs directly.
Copyright (c) 2005 Wiley-Liss, Inc.
Similar articles
-
Assessment of beliefs about psychotropic medication and psychotherapy: development of a measure for patients with anxiety disorders.Gen Hosp Psychiatry. 2005 Sep-Oct;27(5):313-8. doi: 10.1016/j.genhosppsych.2005.05.005. Gen Hosp Psychiatry. 2005. PMID: 16168790
-
Anxiety disorders in primary care.Bull Menninger Clin. 1995 Spring;59(2 Suppl A):A73-85. Bull Menninger Clin. 1995. PMID: 7795573 Review.
-
Primary care perspectives on generalized anxiety disorder.J Clin Psychiatry. 2004;65 Suppl 13:20-6. J Clin Psychiatry. 2004. PMID: 15384933 Review.
-
When worlds converge: Combining depth psychotherapy and psychotropic medications.Bull Menninger Clin. 2006 Fall;70(4):253-72. doi: 10.1521/bumc.2006.70.4.253. Bull Menninger Clin. 2006. PMID: 17166084
-
[Pro and contra: psychotherapy and psychopharmacotherapy attitude of the public].Psychother Psychosom Med Psychol. 1993 Aug;43(8):286-92. Psychother Psychosom Med Psychol. 1993. PMID: 8378520 German.
Cited by
-
The PTSD Family Coach App in Veteran Family Members: Pilot Randomized Controlled Trial.JMIR Form Res. 2023 Jan 5;7:e42053. doi: 10.2196/42053. JMIR Form Res. 2023. PMID: 36602852 Free PMC article.
-
Antidepressant utilization after hospitalization with depression: a comparison between non-Western immigrants and Danish-born residents.BMC Psychiatry. 2014 Mar 17;14:77. doi: 10.1186/1471-244X-14-77. BMC Psychiatry. 2014. PMID: 24636339 Free PMC article.
-
Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study.Scand J Public Health. 2023 Dec;51(8):1222-1230. doi: 10.1177/14034948221112470. Epub 2022 Jul 25. Scand J Public Health. 2023. PMID: 35876428 Free PMC article.
-
Parents' Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders.Child Psychiatry Hum Dev. 2016 Jun;47(3):459-71. doi: 10.1007/s10578-015-0579-2. Child Psychiatry Hum Dev. 2016. PMID: 26349600 Clinical Trial.
-
What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.J Behav Ther Exp Psychiatry. 2009 Sep;40(3):455-67. doi: 10.1016/j.jbtep.2009.06.001. Epub 2009 Jun 12. J Behav Ther Exp Psychiatry. 2009. PMID: 19577224 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical